Make a Difference in Healthcare . Contribute to a Potentially Healthier Tomorrow
- Start date
- Starts Jan 26th
- Therapy area(s)
- Healthy volunteers
- Location
- Austin
- Compensation
- Up to $1600
- Status
-
Enrolling now
No major health conditions
Requirements
Participants must meet the following inclusion criteria to be eligible for this clinical trial:
- Healthy Volunteers
- Ages 18 to 55
- Smoking criteria: Must not be an active user of tobacco, nicotine, or recreational inhalation devices (e.g., vaporizers, ecigarettes, nicotine pouches or patches) or have used these products within 6 months of screening.
- BMI: 19-31.9kg/m2
- Health status is further evaluated by reviewing medical history, screening assessments, and visit with physician
Age: 18-55
Sex: F or M
BMI: 19-31.9
Non-smoker
About study
The study’s purpose is to test the effectiveness of a new investigational inhalation drug-device product aimed to treat those with pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). This is a research study, and your participation is voluntary. You may stop participating at any time. Available and willing to commit to study visit structure: 2 nights in-house, 1 follow-up phone call.
Submit request for call back.
You can sign up by calling the clinic’s call center or request a call back here.
Locations
| Location | Start date | Status |
|---|---|---|
| Austin | Jan 26th |
Enrolling now
|
